Clinical Trials Manager
Dahlia Kamel is a Clinical Trials Coordinator at the Penn FTD Center, who joined the FTD Center in December 2020. Dahlia holds a B.S. in Biology, a B.S. in Psychology with a minor in Neuroscience, a Graduate Certificate in Biostatics and SAS Programming, and an M.S. in Health/Medical Psychology with a concentration in Cognitive Neuroscience. She is currently enrolled in the Interdisciplinary Aging Studies PhD Program at the Tulane University School of Medicine, but is taking a break to work in clinical research. Her published M.S. thesis focused on the associations of cognitive and functional screening measures in patients with Alzheimer’s and Mild Cognitive Impairment, and ways to improve diagnostic use and accuracy. Dahlia is primarily interested in neurodegeneration, neurogenetics, and cognition, and extremely excited about working on cutting-edge genetic therapy trials for patients with frontotemporal lobar degeneration. Dahlia’s previous experience includes clinical research coordinating for Penn Memory Center and Department of Sleep Medicine at the University of Pennsylvania, Graduate research assistant and lab manager for the Cognitive Neuropsychology Lab at the University of the Sciences in Philadelphia, and undergraduate research at the University of North Carolina in the Aging and Cognitive Training Lab.